Data Composite

Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection Shortage

20 of 20 tracked records currently active across 2 manufacturers.

Manufacturers report shortage status per product/package to the FDA independently, so the same generic drug can be short from one company while another still has supply -- the table below breaks that down company by company.

CompanyBrand nameStatusLast updated
Hospira, Inc., a Pfizer Company BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE Current 10/21/2026
Hospira, Inc., a Pfizer Company BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE Current 10/21/2026
Hospira, Inc., a Pfizer Company — Current 10/21/2026
Hospira, Inc., a Pfizer Company — Current 10/21/2026
Hospira, Inc., a Pfizer Company BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE Current 10/21/2026
Hospira, Inc., a Pfizer Company BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE Current 10/21/2026
Hospira, Inc., a Pfizer Company — Current 10/21/2026
Hospira, Inc., a Pfizer Company BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE Current 10/21/2026
Hospira, Inc., a Pfizer Company — Current 10/21/2026
Hospira, Inc., a Pfizer Company — Current 10/21/2026
Hospira, Inc., a Pfizer Company BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE Current 10/21/2026
Hospira, Inc., a Pfizer Company — Current 10/21/2026
Fresenius Kabi USA, LLC SENSORCAINE MPF Current 10/15/2026
Fresenius Kabi USA, LLC SENSORCAINE MPF Current 10/15/2026
Fresenius Kabi USA, LLC SENSORCAINE MPF Current 10/15/2026
Fresenius Kabi USA, LLC SENSORCAINE Current 10/15/2026
Fresenius Kabi USA, LLC SENSORCAINE MPF Current 10/15/2026
Fresenius Kabi USA, LLC SENSORCAINE MPF Current 10/15/2026
Fresenius Kabi USA, LLC SENSORCAINE MPF Current 10/15/2026
Fresenius Kabi USA, LLC SENSORCAINE Current 10/15/2026

← All shortages